» Download Public Reports
38 reports
- Company report
- November 2012
- 3 pages
- by Corporation
... Pluristem to initiate a phase i/ii clinical trial in muscle injury product cand targets orthopedic and sports injuries, addresses a multi-billion dollar annual market haifa, israel ...
October 2012
... Cam & computerized dentistry conference, i was concentrating on aligners, because the market is becoming very huge and a lot of doctors are willing to start using them. Technology is very advanced nowadays, so we ...
September 2012
... Clinical cand that has emerged from the collaboration which the companies entered into in 2008, and will result in a 1 Million milestone payment to ablynx. We are very pleased to see our joint oncology ...
September 2012
... T do it." Warren buffett global market institutional turnover commodity price ** sun pharma, india's largest drug manufactus by market value and engages with specialty medicine and apis for chronic ...
August 2012
... An investment in a hybrid-or is reasonable from a medical, economic and strategically perspective. However, a professional or-management, interdisciplinary collaboration, acquisition of heart surgeons ...
March 2012
... Pipeline beyond cytosorb and betasorb (dialysis), to other development stage technologies that address large markets such as hemodefend (blood transfusion), contrastsorb (imaging and interventional ...
January 2012
... Manufactu planmeca delivers three fully digital teaching environments to king saud university college of dentistry and the na- tional guard of saudi arabia health affairs as part of an extensive local health ...
December 2011
... Resource consumption procedures in orthopaedic surgery [19]. This again is supported by the recent findings of a significant increase of mean treatment costs for infected tka compared to noninfected revision ...
September 2011
... Health pharma- ceuticals general medicine specialty medicine consumer care medical care animal health crop protection / bioscience environmental science bayer corporate center business services technology ...
June 2011
... In markets such as oncology, vaccines, enzyme replacement therapies, and neurology. The fund's investment objective is the greatest possible capital growth. Please refer to legal information on the last page ...